XML 36 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Compensation
 12 Months Ended
Dec. 31, 2022
Share-based Payment Arrangement [Abstract]  
Share-Based Compensation -BASED COMPENSATION
 
On December 31, 2022, the Company had two equity-based compensation plans, which are described below. The Plans do not provide for the settlement of awards in cash and new shares are issued upon option exercise or restricted share grants. 
    In May 2015, the Company adopted the Central Valley Community Bancorp 2015 Omnibus Incentive Plan (2015 Plan). The plan provides for awards in the form of incentive stock options, non-statutory stock options, stock appreciation rights, and restricted stock. The plan also allows for performance awards that may be in the form of cash or shares of the Company’s common stock, including restricted stock. The 2015 plan requires that the exercise price may not be less than the fair market value of the stock at the date the option is granted, and that the option price must be paid in full at the time it is exercised. The options and awards under the plan expire on dates determined by the Board of Directors, but not later than ten years from the date of grant. The vesting period for the options, restricted common stock awards and option related stock appreciation rights is determined by the Board of Directors and is over one to five years. The maximum number of shares that can be issued with respect to all awards under the plan is 875,000. Currently under the 2015 Plan, 737,311 shares remain reserved for future grants as of December 31, 2022.
Effective June 2, 2017, the Company adopted an Employee Stock Purchase Plan whereby our employees may purchase Company common shares through payroll deductions of between one percent and 15 percent of pay in each pay period. Shares are purchased at the end of an offering period at a discount of ten percent from the lower of the closing market price on the Offering Date (first trading day of each offering period) or the Investment Date (last trading day of each offering period). The plan calls for 500,000 common shares to be set aside for employee purchases, and there were 432,056 shares available for future purchase under the plan as of December 31, 2022.
For the years ended December 31, 2022, 2021, and 2020, the compensation cost recognized for share-based compensation was $497,000, $405,000, and $470,000, respectively. The recognized tax benefit for share-based compensation expense was $87,000, $50,000, and $76,000 for 2022, 2021, and 2020 respectively.

No options to purchase shares of the Company’s common stock were granted during the years ending December 31, 2022, 2021 and 2020 from any of the Company’s stock based compensation plans.
A summary of the combined activity of the Plans during the years then ended is presented below (dollars in thousands, except per-share amounts):
SharesWeighted 
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Term (Years)		Aggregate
Intrinsic Value
Options outstanding at January 1, 2020121,120 $8.73 
Options exercised(43,500)$6.39 
Options forfeited(550)$7.40 
Options outstanding at December 31, 202077,070 $10.06 1.51$382 
Options exercised(24,265)$10.6   
Options outstanding at December 31, 202152,805 $9.81 0.57$581 
Options exercised(50,205)$9.74   
Options forfeited(2,600)$11.12   
Options outstanding at December 31, 2022— $— 0.00$— 
 
Information related to the stock option plan during each year follows (in thousands):
202220212020
Intrinsic value of options exercised$496 $253 $433 
Cash received from options exercised$489 $257 $279 
Excess tax benefit realized for option exercises$87 $50 $76 
As of December 31, 2022, there is no unrecognized compensation cost related to stock options granted under all Plans. All options are fully vested.

Restricted Common Stock Awards - The 2015 Plan provide for the issuance of shares to directors and officers. Restricted common stock grants typically vest over a one to five-year period. Restricted common stock (all of which are shares of our common stock) is subject to forfeiture if employment terminates prior to vesting. The cost of these awards is recognized over the vesting period of the awards based on the fair value of our common stock on the date of the grant.
    The following table presents the restricted common stock activity during the years presented: 
 SharesWeighted
Average
Grant Date Fair Value
Nonvested outstanding shares at January 1, 202045,160 $17.38 
Granted21,397 $16.42 
Vested(34,703)$18.23 
Forfeited(1,841)$19.16 
Nonvested outstanding shares at December 31, 202030,013 $15.60 
Granted31,496 $18.83 
Vested(37,085)$15.12 
Forfeited(247)$20.26 
Nonvested outstanding shares at December 31, 202124,177 $20.50 
Granted56,089 $17.75 
Vested(33,316)$20.39 
Forfeited(244)$20.50 
Nonvested outstanding shares at December 31, 202246,706 $17.28 
    The shares awarded to employees and directors under the restricted stock agreements vest on applicable vesting dates only to the extent the recipient of the shares is then an employee or a director of the Company or one of its subsidiaries, and each recipient will forfeit all of the shares that have not vested on the date his or her employment or service is terminated.
    As of December 31, 2022, there were 46,706 shares of restricted stock that are nonvested and expected to vest. Share-based compensation cost charged against income for restricted stock awards was $474,000, $385,000, and $449,000 for the year ended December 31, 2022, 2021, and 2020 respectively.
    As of December 31, 2022, there was $505,000 of total unrecognized compensation cost related to nonvested restricted common stock.  Restricted stock compensation expense is recognized on a straight-line basis over the vesting period. This cost is expected to be recognized over a weighted average remaining period of 2.01 years and will be adjusted for subsequent changes in estimated forfeitures. Restricted common stock awards had an intrinsic value of $3,825,000 at December 31, 2022.